ImmunoConcEpT - UMR 5164: Recent submissions
Now showing items 21-40 of 379
-
Evaluation of Facial Vitiligo Severity with a Mixed Clinical and Artificial Intelligence Approach
(Journal of Investigative Dermatology. vol. 144, n° 2, pp. 351 – 357.e4, 2024-02)Article de revue -
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
(Nature Communications. vol. 15, n° 1, 2024-08)Article de revueOpen access -
Characterisation of the novel HLA-DPB1*1618:01 allele by sequencing-based typing
(HLA. vol. 104, n° 3, 2024-09)Article de revue -
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
(Joint Bone Spine. vol. 91, n° 5, 2024-09)Article de revueOpen access -
Characterization of the novel HLA-B*51:394Q allele by sequencing-based typing
(HLA. vol. 103, n° 2, 2024-02)Article de revue -
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks
(Journal of the European Academy of Dermatology and Venereology, 2024-07)Article de revueOpen access -
The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients over the First Year Posttransplantation
(Transplantation Direct. vol. 10, n° 8, pp. e1678, 2024-08)Article de revueOpen access -
Characterisation of the novel HLA-A*26:247 allele by sequencing-based typing
(HLA. vol. 104, n° 3, 2024-09)Article de revue -
Characterisation of the novel HLA-DQA1*01:02:24 allele by sequencing-based typing
(HLA. vol. 104, n° 3, 2024-09)Article de revue -
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
(Journal of the European Academy of Dermatology and Venereology. vol. 38, n° 7, pp. 1251 – 1280)Article de revue -
Methodological advice for the young at heart investigator: Triangulation to build better foundations
(Brain, Behavior, and Immunity. vol. 115, pp. 737 – 746, 2024-01)Article de revueOpen access -
Ultra-overt therapy: a novel medical approach centered on patient consciousness
(Frontiers in Integrative Neuroscience. vol. 18, 2024-08)Article de revueOpen access -
Inflated expectations: the strange craze for translational research on aging: Given existing confusion about the basic science of aging, why the high optimism in the private sector about the prospects of developing anti-aging treatments?
(EMBO Reports. vol. 25, n° 9, pp. 3748 – 3752, 2024-08)Article de revueOpen access -
Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease
(Journal of clinical immunology. vol. 44, n° 2, 2024-01)Article de revue -
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration
(Journal of Clinical Investigation. vol. 134, n° 11, 2024-04)Article de revueOpen access -
Characterisation of the novel HLA-DRB1*08:126 allele by sequencing-based typing
(HLA. vol. 104, n° 2, 2024-08)Article de revue -
The Microscope and Beyond: Current Trends in the Characterization of Kidney Allograft Rejection From Tissue Samples
(Transplantation, 2024-08)Article de revue -
Characterization of the novel HLA-DRB1*04:04:20 allele by sequencing-based typing
(HLA. vol. 103, n° 3, 2024-03)Article de revue -
Les temps forts de la transplantation rénale en 2023
(Nephrologie & therapeutique. vol. 20, n° S1, pp. 1 – 9, 2024-03)Article de revue